Pharmacokinetics of Isoniazid in Low-Birth-Weight and Premature Infants

Isoniazid (INH) is recommended for use as posttuberculosis exposure preventive therapy in children. However, no pharmacokinetic data are available for INH treatment in low-birth-weight (LBW) infants, who undergo substantial developmental and physiological changes. Our objectives in this study were t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bekker, A., Schaaf, H. S., Seifart, H. I., Draper, H. R., Werely, C. J., Cotton, M. F., Hesseling, A. C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2014
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4023760/
https://ncbi.nlm.nih.gov/pubmed/24492365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01532-13
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak